glp-1 atrial fibrillation How should clinicians choose between and SGLT-2 therapies for patients with (Afib) and Type 2 diabetes? 🫀 New research from #UBuffalo SPPS provides important evidence to help guide that If you take a GLP-1

To qualify, besides having Medicare drug coverage, applicants must have a body mass index of 35 or higher, or a BMI of 27 or higher alongside another health condition, such as a past heart attack or stroke, prediabetes or another from a list on the Centers for Medicare & Medicaid Services website

We also added GBBGO (aka Super Carnitine) turns up the heat with intense thermogenesis increasing sweat and fat metabolism for maximum calorie burn

There are some rare but serious risks, like inflammation of the pancreas or thyroid concerns

Reply to comment on the effect of semaglutide and GLP-1 RAs on risk of nonarteritic anterior ischemic optic neuropathy [published online ahead of print June 20, 2025]

Council on Epidemiology and Prevention